Prognostic factors in heart failure patients with cardiac cachexia

被引:0
|
作者
Yu Sato [1 ]
Akiomi Yoshihisa [1 ,2 ]
Yusuke Kimishima [1 ]
Tetsuro Yokokawa [1 ]
Satoshi Abe [1 ]
Takeshi Shimizu [1 ]
Tomofumi Misaka [1 ,2 ]
Shinya Yamada [1 ]
Takamasa Sato [1 ]
Takashi Kaneshiro [1 ]
Masayoshi Oikawa [1 ]
Atsushi Kobayashi [1 ]
Takayoshi Yamaki [1 ]
Hiroyuki Kunii [1 ]
Yasuchika Takeishi [1 ]
机构
[1] Department of Cardiovascular Medicine, Fukushima Medical University
[2] Department of Advanced Cardiac Therapeutics, Fukushima Medical University
基金
日本学术振兴会;
关键词
Body mass index; Cachexia; Heart failure; Mortality; Prognosis;
D O I
暂无
中图分类号
R541.6 [血液循环衰竭];
学科分类号
1002 ; 100201 ;
摘要
Objective To clarify whether cardiac cachexia(CC) alters the prognostic impact of other general risk factors in patients with heart failure(HF). Methods This was an observational study. CC was defined as the combination of a body mass index of < 20 kg/m~2 and at least one of the following biochemical abnormalities: C-reactive protein > 5 mg/L; hemoglobin < 12 g/dL; and/or albumin < 3.2 g/d L. We divided 1608 hospitalized HF patients into a CC group(n=176, 10.9%) and a non-CC group(n=1432, 89.1%). The primary endpoints were cardiac event and all-cause death. Results The presence of CC showed significant interactions with other risk factors including cancer, estimated glomerular filtration rate(eGFR), and sodium in predicting these endpoints. Multiple Cox proportional analysis revealed that use of a blockers [hazard ratio(HR)=1.900, 95% confidence interval(CI):1.045–3.455, P=0.035) and eGFR(HR=0.989, 95% CI: 0.980–0.998, P=0.018) were independent predictors of cardiac event in the CC group, while age(HR=1.020, 95% CI: 1.002–1.039, P=0.029) and hemoglobin(HR=0.844, 95% CI: 0.734–0.970, P=0.017) were independent predictors of all-cause death. The survival classification and regression tree analysis showed the optimal cut-off points for cardiac event(eGFR: 59.9 m L/min per 1.73 m~2) and all-cause death(age, 83 years old; hemoglobin, 10.1 g/dL) in the CC group. Conclusions In predicting prognosis, CC showed interactions with several risk factors. Renal function, age, and hemoglobin were pivotal markers in HF patients with CC.
引用
收藏
页码:26 / 34
页数:9
相关论文
共 50 条
  • [31] The prognostic impact of recurrent cardiac hospitalizations in patients with heart failure
    Lee, Douglas S.
    Austin, Peter C.
    Stukel, Therese A.
    Alter, David A.
    Chong, Alice
    Parker, John D.
    Tu, Jack V.
    CIRCULATION, 2008, 117 (21) : E448 - E448
  • [32] Sarcopenia and cachexia in hospitalized heart failure patients
    Costa, Ana-Jessyca da Silva
    Sabino-Pinho, Claudia Porto
    Mendes, Roberta-Maria Lins
    Santos, Natalia Fernandes
    NUTRITION CLINIQUE ET METABOLISME, 2023, 37 (02): : 87 - 93
  • [33] Prevalence and effect of cardiac cachexia in advanced heart failure patients living in northern ireland
    Carson, M.
    Reid, J.
    Hill, L.
    Dixon, L.
    Donnelly, P.
    Slater, P.
    Hill, A.
    Fitzsimons, D.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2021, 20 : 46 - 46
  • [34] Increased serum levels of metalloproteinases and their tissue inhibitors in patients with heart failure and cardiac cachexia
    Filippatos, G
    Xydonas, S
    Prosmiti, N
    Manolatos, D
    Kardara, D
    Krokos, B
    Drougas, G
    Kardaras, F
    EUROPEAN HEART JOURNAL, 2002, 23 : 648 - 648
  • [35] Associations of cachexia and prognosis in patients with heart failure
    Morishita, T.
    Uzui, H.
    Ishida, K.
    Kaseno, K.
    Miyazaki, S.
    Fukuoka, Y.
    Ikeda, H.
    Tama, N.
    Shiomi, Y.
    Yamaguchi, J.
    Sato, Y.
    Aoyama, D.
    Ishikawa, E.
    Miyahara, K.
    Tada, H.
    EUROPEAN HEART JOURNAL, 2018, 39 : 986 - 986
  • [36] Prognostic Impact and Prevalence of Cachexia in Patients With Heart Failure: A Systematic Review and Meta-Analysis
    Prokopidis, Konstantinos
    Irlik, Krzysztof
    Hendel, Mirela
    Piasnik, Julia
    Lip, Gregory Y. H.
    Nabrdalik, Katarzyna
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2024, 15 (06) : 2536 - 2543
  • [37] From Heart Failure to Cardiac Cachexia: Clinical Aspects and Pathophysiology
    Kung, T.
    von Haehling, S.
    AKTUELLE ERNAHRUNGSMEDIZIN, 2009, 34 (04): : E1 - E10
  • [38] Cachexia assessed by bioimpedance vector analysis as a prognostic indicator in chronic stable heart failure patients
    Castillo-Martinez, Lilia
    Colin-Ramirez, Eloisa
    Orea-Tejeda, Arturo
    Gonzalez Islas, Dulce Gabriela
    Rodriguez Garcia, Wendy Daniella
    Santillan Diaz, Cira
    Gutierrez Rodriguez, Ana Elizabeth
    Vazquez Duran, Marisela
    Davies, Candace Keirns
    NUTRITION, 2012, 28 (09) : 886 - 891
  • [39] Prognostic value of bioimpedance vector analysis-assessed cachexia in patients with decompensated heart failure
    Klimenko, A.
    Rakisheva, A.
    Villevalde, S.
    Kobalava, Z.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 269 - 270
  • [40] Heart failure and cachexia
    Tabet, J. Y.
    Meurin, P.
    Ben Driss, A.
    Logeart, D.
    Helies-Toussasint, C.
    Tartiere, J. M.
    Cohen-Solal, A.
    Grynberg, A.
    Bourdel-Marchasson, I.
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2006, 99 (12): : 1203 - 1209